ArticleClinical lung cancer2022

Extended Delay to Treatment for Stage III-IV Non-Small-Cell Lung Cancer and Survival: Balancing Risks During the COVID-19 Pandemic.

Nicholas R Mayne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.